Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers: A Preliminary Study | Neuropsychopharmacology
Receptor Occupancy Assay | Melior Discovery
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects | Journal of Medicinal Chemistry
Buprenorphine/Naloxone Toxicity: Practice Essentials, Background, Pathophysiology
File:Buprenorphine-naloxone action at opioid receptor.png - Wikimedia Commons
Understanding opioids in veterinary medicine
The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review
Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization | Journal of Neuroscience
Buprenorphine: Considerations for Pain Management - ScienceDirect
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE
Perioperative Management of Opioid Use Disorder Patients on Buprenorphine/Naloxone : WFSA - Resources
Buprenorphine/samidorphan - Wikipedia
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE
Medications Used in Opioid Maintenance Treatment
Buprenorphine - Wikipedia
Clinical Aspects of Buprenorphine Therapy - YouTube
Opioid Use Disorder Medications - Pharmacokinetics Buprenorphine ... | GrepMed
Buprenorphine for Opioid Use Disorder: Mechanism of Action - Psychopharmacology Institute
emDOCs.net – Emergency Medicine EducationBuprenorphine: Where do we stand? - emDOCs.net - Emergency Medicine Education
AANA Journal Course—Demystifying Buprenorphine with Current Evidence- Based Practice in Acute and Chronic Pain Management AANA Journal : June 2022
Should buprenorphine be discontinued preoperatively? – Depth of Anesthesia
Frontiers | Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
